SEC Form 4 · accession 0001203311-15-000054
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clay B Siegall
Officer — President and CEO · Director
Period of report
Oct 5, 2015
Accepted (ET)
Oct 7, 2015 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 5, 2015 | M | 3,718 | $5.63 | A | 615,041 | D | |
| Common StockF2,F3 | Oct 5, 2015 | S | 3,718 | $41.2966 | D | 611,323 | D | |
| Common Stock | holding | — | — | — | 27,945 | I | by Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F4 | $5.63 | Oct 5, 2015 | M | 3,718 | D | — | Jan 31, 2016 | Common Stock | 3,718 | 7,438 | D |
Explanation of responses
- F1The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan.
- F2Sale price represents a weighted average price for all shares sold on this day, which are within a $1.00 range.
- F3Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- F4Shares vested at a rate of 25% on 1/31/07 and monthly thereafter until all the shares were fully vested on 1/31/10.